Stereotaxis, Inc.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
STXS$1.03-9.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2025 and 2024
STEREOTAXIS, INC.
| (in thousands, except share amounts) | December 31, 2025 | December 31, 2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $13,421 | $12,217 |
| Restricted cash - current | - | 219 |
| Accounts receivable, net of allowance of $541 and $582 at 2025 and 2024, respectively | 5,847 | 3,824 |
| Insurance receivable | 4,316 | - |
| Inventories, net | 9,567 | 8,331 |
| Prepaid expenses and other current assets | 698 | 1,848 |
| Total current assets | 33,849 | 26,439 |
| Property and equipment, net | 3,019 | 3,573 |
| Goodwill | 3,764 | 3,764 |
| Intangible assets, net | 6,429 | 7,358 |
| Operating lease right-of-use assets | 4,912 | 5,483 |
| Prepaid and other non-current assets | 278 | 107 |
| Total assets | $52,251 | $46,724 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $4,768 | $5,668 |
| Accrued liabilities | 2,065 | 2,922 |
| Accrued legal liabilities | 4,316 | - |
| Deferred revenue | 5,675 | 6,804 |
| Current contingent consideration | 4,894 | 5,638 |
| Current portion of operating lease liabilities | 642 | 570 |
| Total current liabilities | 22,360 | 21,602 |
| Long-term deferred revenue | 555 | 2,064 |
| Long term contingent consideration | 4,724 | 6,126 |
| Operating lease liabilities | 4,794 | 5,436 |
| Other liabilities | 1,097 | 64 |
| Total liabilities | 33,530 | 35,292 |
| Series A - Convertible preferred stock: | ||
| Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized; 21,008 and 21,458 shares outstanding at 2025 and 2024, respectively | 5,240 | 5,352 |
| Stockholders’ equity: | ||
| Common stock, par value $0.001; 300,000,000 shares authorized, 95,339,628 and 85,326,557 shares issued at 2025 and 2024, respectively | 95 | 85 |
| Additional paid in capital | 596,960 | 567,926 |
| Treasury stock, 4,015 shares at 2025 and 2024 | (206) | (206) |
| Accumulated deficit | (583,368) | (561,725) |
| Total stockholders’ equity | 13,481 | 6,080 |
| Total liabilities and stockholders’ equity | $52,251 | $46,724 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.